Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Plyukhova Aa"'
Autor:
Plyukhova Aa, A A Ryabtseva, Mazurina Nk, S V Simonova, Kuroedov Av, M V Budzinskaya, Razik S, Loskutov Ia, Egorov Ae
Publikováno v:
Vestnik oftalmologii. 131(6)
Neovascular complications severity in central/branch retinal vein occlusion (RVO) correlates with the level of occlusion and the degree of retinal perfusion disturbance. Large areas of retinal non-perfusion (more than half of the total retinal area)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b3e0bf2b72d25aa4352e40d3b86151
https://pubmed.ncbi.nlm.nih.gov/26977729
https://pubmed.ncbi.nlm.nih.gov/26977729
Autor:
Mazurina Nk, S V Simonova, M V Budzinskaya, Kuroedov Av, Loskutov Ia, Razik S, A A Ryabtseva, Plyukhova Aa, Egorov Ae
Publikováno v:
Vestnik oftalmologii. 131(6)
Considering an upward global trend in cardiovascular disease rates, retinal vein occlusion (RVO) in particular, development of therapeutic guidelines is a pressing issue in ophthalmology. Risk factors for RVO include hypertension, atherosclerosis, di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::920b80d75fff01dfdc37bc2517b9fd42
https://pubmed.ncbi.nlm.nih.gov/26977727
https://pubmed.ncbi.nlm.nih.gov/26977727
Autor:
Plyukhova Aa, A A Ryabtseva, Kuroedov Av, Egorov Ae, S V Simonova, Razik S, Loskutov Ia, Mazurina Nk, M V Budzinskaya
Publikováno v:
Vestnik oftalmologii. 131(6)
Macular edema (ME) is the most common complication of both ischemic and nonischemic retinal vein occlusion (RVO). If the main trunk of the central retinal vein is involved, ME occurs in 100% of cases. According to the Central Vein Occlusion Study, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05cc80942978385a83e613d78a3a9950
https://pubmed.ncbi.nlm.nih.gov/26977728
https://pubmed.ncbi.nlm.nih.gov/26977728
Autor:
Mario Damiano Toro, Michele Reibaldi, M.V. Budzinskaya, Robert Rejdak, Claudio Bucolo, Kirill M Starostin, Anna Plyukhova
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 1522, p 1522 (2020)
Journal of Clinical Medicine, Vol 9, Iss 1522, p 1522 (2020)
Background: Since the efficacy of ranibizumab (RBZ), bevacizumab (BVZ) and aflibercept (AFB) is comparable in neovascular age-related macular degeneration (AMD), we conducted a systematic review and meta-analysis to evaluate the long-term safety prof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::525fea6dc0a7721784bfc369b328c08d
https://doi.org/10.3390/jcm9051522
https://doi.org/10.3390/jcm9051522
Autor:
Yusef YN; Krasnov Research Institute of Eye Diseases, Moscow, Russia.; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Budzinskaya MV; Krasnov Research Institute of Eye Diseases, Moscow, Russia., Plyukhova AA; Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Publikováno v:
Vestnik oftalmologii [Vestn Oftalmol] 2023; Vol. 139 (4), pp. 115-120.
Autor:
Budzinskaya MV; Krasnov Research Institute of Eye Diseases, Moscow, Russia., Plyukhova AA; Krasnov Research Institute of Eye Diseases, Moscow, Russia., Alkharki L; Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Publikováno v:
Vestnik oftalmologii [Vestn Oftalmol] 2023; Vol. 139 (3. Vyp. 2), pp. 46-50.
Autor:
Yusef YN; Krasnov Research Institute of Eye Diseases, Moscow, Russia.; Sechenov First Moscow State Medical University, Moscow, Russia., Budzinskaya MV; Krasnov Research Institute of Eye Diseases, Moscow, Russia., Plyukhova AA; Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Publikováno v:
Vestnik oftalmologii [Vestn Oftalmol] 2023; Vol. 139 (3. Vyp. 2), pp. 51-55.
Autor:
Budzinskaya MV; Research Institute of Eye Diseases, Moscow, Russia., Plyukhova AA; Research Institute of Eye Diseases, Moscow, Russia., Afanasyeva MA; Research Institute of Eye Diseases, Moscow, Russia., Gorkavenko FV; Center for Healthcare Quality Assessment and Control, Moscow, Russia.
Publikováno v:
Vestnik oftalmologii [Vestn Oftalmol] 2022; Vol. 138 (4), pp. 58-66.
Autor:
Budzinskaya MV; Research Institute of Eye Diseases, Moscow, Russia., Shelankova AV; Research Institute of Eye Diseases, Moscow, Russia., Andreeva AA; Research Institute of Eye Diseases, Moscow, Russia., Plyukhova AA; Research Institute of Eye Diseases, Moscow, Russia., Afanasyeva MA; Research Institute of Eye Diseases, Moscow, Russia.
Publikováno v:
Vestnik oftalmologii [Vestn Oftalmol] 2021; Vol. 137 (5), pp. 7-13.
Autor:
Sheremet NL; Research Institute of Eye Diseases, Moscow, Russia., Mikaelyan AA; Research Institute of Eye Diseases, Moscow, Russia., Andreev AY; Krasnogorsk City Hospital No 1, Krasnogorsk, Russia.; Imtek LLC, Moscow, Russia., Plyukhova AA; Research Institute of Eye Diseases, Moscow, Russia., Andreeva NA; Research Institute of Eye Diseases, Moscow, Russia., Kiselev SL; Vavilov Institute of General Genetics, Moscow, Russia.
Publikováno v:
Vestnik oftalmologii [Vestn Oftalmol] 2021; Vol. 137 (1), pp. 5-12.